Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Jan 14, 2020 09:33 PM IST | Source: PTI

USFDA classifies inspection of Lupin's Tarapur facility as 'Official Action Indicated'

"The company has received a communication from the US FDA classifying the inspection conducted at its Tarapur manufacturing (API) facility between September 16 to September 20, 2019 as Official Action Indicated (OAI)," Lupin Ltd said in a filing to BSE.

Lupin Ltd on Monday said the US health regulator has cautioned that its Tarapur manufacturing facility may be subject to regulatory actions.

"The company has received a communication from the US FDA classifying the inspection conducted at its Tarapur manufacturing (API) facility between September 16 to September 20, 2019 as Official Action Indicated (OAI)," Lupin Ltd said in a filing to BSE.

According to FDA's definitions, Official Action Indicated means "objectionable conditions were found and regulatory administrative sanctions by FDA are indicated" during inspections.

Close

The inspection at the Tarapur facility had closed with three observations.

The company, however, said that it does not believe this inspection classification will have an impact on disruption of supplies or the existing revenues from operations of this facility.

"The company is in the process of sending further updates of its corrective actions to the US FDA and is hopeful of a positive outcome," the filing said.

The shares of Lupin were trading at Rs 750.60, down 1.11 percent on BSE in morning trade.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jan 13, 2020 10:45 am
Sections
Follow us on